These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Non-dystrophic myotonia: prospective study of objective and patient reported outcomes. Trivedi JR; Bundy B; Statland J; Salajegheh M; Rayan DR; Venance SL; Wang Y; Fialho D; Matthews E; Cleland J; Gorham N; Herbelin L; Cannon S; Amato A; Griggs RC; Hanna MG; Barohn RJ; Brain; 2013 Jul; 136(Pt 7):2189-200. PubMed ID: 23771340 [TBL] [Abstract][Full Text] [Related]
3. Non-dystrophic myotonias: clinical and mutation spectrum of 70 German patients. Vereb N; Montagnese F; Gläser D; Schoser B J Neurol; 2021 May; 268(5):1708-1720. PubMed ID: 33263785 [TBL] [Abstract][Full Text] [Related]
4. Clinical comparison and functional study of the L703P: a recurrent mutation in human SCN4A that causes sodium channel myotonia. Ke Q; Zhao Y; Li Y; Ye J; Tang S; He F; Ji F; Dai X; Ni J; Li Y; Griggs RC; Cheng X Neuromuscul Disord; 2022 Oct; 32(10):811-819. PubMed ID: 36050252 [TBL] [Abstract][Full Text] [Related]
5. Mutation spectrum and health status in skeletal muscle channelopathies in Japan. Sasaki R; Nakaza M; Furuta M; Fujino H; Kubota T; Takahashi MP Neuromuscul Disord; 2020 Jul; 30(7):546-553. PubMed ID: 32660787 [TBL] [Abstract][Full Text] [Related]
6. Genetic spectrum and founder effect of non-dystrophic myotonia: a Japanese case series study. Yuan JH; Higuchi Y; Hashiguchi A; Ando M; Yoshimura A; Nakamura T; Sakiyama Y; Takashima H J Neurol; 2022 Dec; 269(12):6406-6415. PubMed ID: 35907044 [TBL] [Abstract][Full Text] [Related]
7. Coexistence of CLCN1 and SCN4A mutations in one family suffering from myotonia. Maggi L; Ravaglia S; Farinato A; Brugnoni R; Altamura C; Imbrici P; Camerino DC; Padovani A; Mantegazza R; Bernasconi P; Desaphy JF; Filosto M Neurogenetics; 2017 Dec; 18(4):219-225. PubMed ID: 28993909 [TBL] [Abstract][Full Text] [Related]
8. SCN4A variants and Brugada syndrome: phenotypic and genotypic overlap between cardiac and skeletal muscle sodium channelopathies. Bissay V; Van Malderen SC; Keymolen K; Lissens W; Peeters U; Daneels D; Jansen AC; Pappaert G; Brugada P; De Keyser J; Van Dooren S Eur J Hum Genet; 2016 Mar; 24(3):400-7. PubMed ID: 26036855 [TBL] [Abstract][Full Text] [Related]
9. Functional and Structural Characterization of ClC-1 and Na Brenes O; Barbieri R; Vásquez M; Vindas-Smith R; Roig J; Romero A; Valle GD; Bermúdez-Guzmán L; Bertelli S; Pusch M; Morales F Cells; 2021 Feb; 10(2):. PubMed ID: 33670307 [TBL] [Abstract][Full Text] [Related]
10. A c.1775C > T Point Mutation of Sodium Channel Alfa Subunit Gene (SCN4A) in a Three-Generation Sardinian Family with Sodium Channel Myotonia. Campanale C; Laghetti P; Saltarella I; Altamura C; Canioni E; Iosa E; Maggi L; Brugnoni R; Tacconi P; Desaphy JF J Neuromuscul Dis; 2024; 11(3):725-734. PubMed ID: 38427496 [TBL] [Abstract][Full Text] [Related]
11. Myotonia congenita and myotonic dystrophy in the same family: coexistence of a CLCN1 mutation and expansion in the CNBP (ZNF9) gene. Sun C; Van Ghelue M; Tranebjærg L; Thyssen F; Nilssen Ø; Torbergsen T Clin Genet; 2011 Dec; 80(6):574-80. PubMed ID: 21204798 [TBL] [Abstract][Full Text] [Related]
12. A case of non-dystrophic myotonia with concomitant mutations in the SCN4A and CLCN1 genes. Kato H; Kokunai Y; Dalle C; Kubota T; Madokoro Y; Yuasa H; Uchida Y; Ikeda T; Mochizuki H; Nicole S; Fontaine B; Takahashi MP; Mitake S J Neurol Sci; 2016 Oct; 369():254-258. PubMed ID: 27653901 [TBL] [Abstract][Full Text] [Related]
14. Prevalence and mutation spectrum of skeletal muscle channelopathies in the Netherlands. Stunnenberg BC; Raaphorst J; Deenen JCW; Links TP; Wilde AA; Verbove DJ; Kamsteeg EJ; van den Wijngaard A; Faber CG; van der Wilt GJ; van Engelen BGM; Drost G; Ginjaar HB Neuromuscul Disord; 2018 May; 28(5):402-407. PubMed ID: 29606556 [TBL] [Abstract][Full Text] [Related]
15. p.Asn1180Ile mutation of SCN4A gene in an Italian family with myopathy and myotonic syndrome. Rigamonti A; Mantero V; Peverelli L; Pagliarani S; Lucchiari S; Comi G; Gibertini S; Salmaggi A Neurol Sci; 2021 Dec; 42(12):5359-5363. PubMed ID: 34378097 [TBL] [Abstract][Full Text] [Related]
16. In tandem analysis of CLCN1 and SCN4A greatly enhances mutation detection in families with non-dystrophic myotonia. Trip J; Drost G; Verbove DJ; van der Kooi AJ; Kuks JB; Notermans NC; Verschuuren JJ; de Visser M; van Engelen BG; Faber CG; Ginjaar IB Eur J Hum Genet; 2008 Aug; 16(8):921-9. PubMed ID: 18337730 [TBL] [Abstract][Full Text] [Related]
17. Improving the understanding of how patients with non-dystrophic myotonia are selected for myotonia treatment with mexiletine (NaMuscla): outcomes of treatment impact using a European Delphi panel. Chapman AM; Schurer M; Weijers L; Omar A; Lee H; Weidenfeller AZ; Ellis C; Sonecha S; Schneider-Gold C BMC Neurol; 2021 Dec; 21(1):467. PubMed ID: 34852780 [TBL] [Abstract][Full Text] [Related]